MedTrace Logo

Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units

NCT06392568 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-04-30

No results posted yet for this study

Summary

Investigate the epidemiology, risk factors and impact on clinical practice of healthcare-associated infections with emergent highly drug-resistant (eHDR) pathogens, particularly carbapenem resistant enterobacteriaceae and glycopeptides-resistant enterococcus.

Conditions

  • Cross Infection
  • Carbapenem Resistant Bacterial Infection
  • Vancomycin-Resistant Enterococcal Infection
  • Critical Illness

Interventions

OTHER

epidemiological records

Healthcare associated infections due to emergent highly resistant bacteria, sites, risk factors, treatment and outcome

Sponsors & Collaborators

  • Abderrahmane Mami Hospital

    lead OTHER

Principal Investigators

  • Amira JAMOUSSI, Professor · Abderrahmen Mami Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • Tunisia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06392568 on ClinicalTrials.gov